Key result
Oral ondansetron reduced the incidence of postoperative nausea and/or vomiting compared to placebo following major gynaecological surgery.
Why the study?
Does oral ondansetron prevent postoperative nausea and vomiting in patients undergoing major gynaecological surgery under general anaesthesia?
RCT (n=243)
double-blind
randomised
Yes
Does oral ondansetron prevent postoperative nausea and vomiting in patients undergoing major gynaecological surgery under general anaesthesia?
Oral ondansetron 8 mg given in three doses starting before surgery significantly reduces the incidence and severity of postoperative nausea and vomiting after major gynaecological surgery.
Answers are grounded in this paper and cite their sources.
Supports oral ondansetron prophylaxis in major gynaecological surgery; confirms RCT efficacy for PONV reduction in high-risk patients.
The efficacy and safety of ondansetron in preventing postoperative nausea and vomiting following major gynaecological surgery was evaluated in this multicentre, double-blind study. A total of 243 patients were randomised to receive three doses of oral ondansetron 8 mg or matching placebo at 8-hourly intervals, with the first dose being given an hour before surgery. A standard general anaesthetic technique was employed throughout. Nausea, vomiting and safety assessments were performed continuously during the 24 h postrecovery period. Of the 237 patients evaluated for efficacy, significantly fewer ondansetron 8 mg treated patients (65/117; 56%) experienced postoperative nausea and/or vomiting compared with placebo-treated patients (94/120; 78%) during the study period (p < 0.001). In addition, ondansetron 8 mg reduced the severity of nausea (p < 0.001) and the total number of vomiting episodes experienced (p < 0.001). Overall, ondansetron 8 mg was well tolerated and effective in preventing postoperative nausea and vomiting in this surgical setting.
No takes yet. Share an insight, caveat, or question.
Dupeyron et al. (1993) conducted an RCT in postoperative nausea and vomiting (n=243). oral ondansetron vs. matching placebo was evaluated on postoperative nausea and/or vomiting (p=< 0.001). Oral ondansetron reduced the incidence of postoperative nausea and/or vomiting compared to placebo following major gynaecological surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: